PNMT (Phenylethanolamine N-Methyltransferase)

Key enzyme in catecholamine biosynthesis, converting norepinephrine to epinephrine

Gene Information Card

Symbol PNMT
Full Name Phenylethanolamine N-Methyltransferase
Gene Type Protein coding
Chromosomal Location 17q12
NCBI Gene ID 5409 ncbi.nlm.nih.gov/gene/5409
Ensembl ID ENSG00000108433
UniProt ID P11086
OMIM ID 171190
HGNC ID 9160
Aliases PENT, PNMTase

Description

The PNMT gene encodes phenylethanolamine N-methyltransferase, an enzyme that catalyzes the final step in catecholamine biosynthesis: the conversion of norepinephrine to epinephrine (adrenaline). PNMT is primarily expressed in the adrenal medulla and in certain brain regions. It plays a critical role in the stress response, blood pressure regulation, and neurotransmission. Genetic variations in PNMT have been associated with hypertension and psychiatric disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypertension Altered PNMT activity may affect epinephrine levels, influencing blood pressure regulation. ClinVar, OMIM
Postural Tachycardia Syndrome Dysregulation of catecholamine synthesis due to PNMT variants may contribute to autonomic dysfunction. NCBI Gene, OMIM
Bipolar Disorder PNMT expression changes in brain regions linked to mood regulation; association studies suggest genetic risk. OMIM, NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Adrenal Gland 112.5 High
Brain (Medulla Oblongata) 8.2 Medium
Heart 1.3 Low
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
Adrenal Cortex Cells 45.6 High expression
SH-SY5Y (Neuroblastoma) 12.3 Moderate expression
HEK293 0.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.148G>A (p.Ala49Thr) Missense <0.01% Reduced enzyme activity; associated with hypertension risk
c.199C>T (p.Arg67Cys) Missense <0.01% Decreased catalytic efficiency; linked to altered stress response
c.−282G>A Promoter variant 0.5% Alters transcription factor binding; may affect expression levels
Mutation functional classification

Loss of Function (LOF)

Missense variants such as p.Ala49Thr reduce PNMT enzymatic activity, leading to decreased epinephrine synthesis.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in PNMT.

Dominant Negative (DN)

No evidence of dominant-negative effects for PNMT mutations.

Gene Ontology (GO)

• Phenylethanolamine N-methyltransferase activity • Catecholamine biosynthetic process
• Response to stress • Adrenal gland development
• Norepinephrine metabolic process

Pathways

Catecholamine biosynthesis
Tyrosine metabolism
Neuroactive ligand-receptor interaction

Protein Summary

Phenylethanolamine N-methyltransferase (PNMT) is a 30.4 kDa cytosolic enzyme that catalyzes the methylation of norepinephrine to epinephrine using S-adenosylmethionine as a methyl donor. The protein is highly expressed in the adrenal medulla and in specific brainstem nuclei. PNMT activity is regulated by glucocorticoids and is essential for the synthesis of epinephrine, a key hormone in the fight-or-flight response. Structural studies reveal a conserved methyltransferase fold with a substrate-binding pocket specific for phenylethanolamine derivatives.

Related Products

Product name Cat.No. Species Gene ID
PNMT Knockout HEK293 Cell Line EDJ-KQ2279 Human 5409 Details Get a Quote
PNMT Knockout HeLa Cell Line EDJ-KQ54167 Human 5409 Details Get a Quote
PNMT Knockout A-549 Cell Line EDJ-KQ62664 Human 5409 Details Get a Quote
PNMT Knockout HCT 116 Cell Line EDJ-KQ71131 Human 5409 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: